Journal Home
Search for

Volume 19, Issue 6, Pages 406-414 (November 2009)


View previous. 10 of 14 View next.

State-Level Differences in Breast and Cervical Cancer Screening by Disability Status: United States, 2008

Brian S. Armour, PhDaCorresponding Author Informationemail address, JoAnn M. Thierry, PhDa, Lesley A. Wolf, MPHb

Received 20 March 2009; received in revised form 28 August 2009; accepted 28 August 2009.

Introduction and Background

Despite reported disparities in the use of preventive services by disability status, there has been no national surveillance of breast and cervical cancer screening among women with disabilities in the United States. To address this, we used state-level surveillance data to identify disparities in breast and cervical cancer screening among women by disability status.

Methods

Data from the 2008 Behavioral Risk Factor Surveillance System were used to estimate disability prevalence and state-level differences in breast and cervical cancer screening among women by disability status.

Results

Overall, modest differences in breast cancer screening were found; women with a disability were less likely than those without to report receiving a mammogram during the past 2 years (72.2% vs. 77.8%; p < .001). However, disparities in breast cancer screening were more pronounced at the state level. Furthermore, women with a disability were less likely than those without a disability to report receiving a Pap test during the past 3 years (78.9% vs. 83.4%; p < .001).

Discussion

This epidemiologic evidence identifies an opportunity for federal and state programs, as well as other stakeholders, to form partnerships to align disability and women's health policies. Furthermore, it identifies the need for increased public awareness and resource allocation to reduce barriers to breast and cervical cancer screening experienced by women with disabilities.

a Division of Human Development and Disability, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia

b Science Applications International Corporation, Atlanta, Georgia

Corresponding Author InformationCorrespondence to: Dr. Brian Armour, 1600 Clifton Road, N.E., Mail Stop E-88, Atlanta, Georgia 30333; Phone: 404-498-3014; fax: 404-498-3060.

 The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

PII: S1049-3867(09)00100-5

doi:10.1016/j.whi.2009.08.006


View previous. 10 of 14 View next.